PDB56 PHARMACOECONOMIC CONSEQUENCES OF LOSARTAN THERAPY IN PATIENTS UNDERGOING DIABETIC END-STAGE RENAL DISEASE IN EU AND USA
Nov 1, 2010, 00:00
10.1016/S1098-3015(11)72114-3
https://www.valueinhealthjournal.com/article/S1098-3015(11)72114-3/fulltext
Title :
PDB56 PHARMACOECONOMIC CONSEQUENCES OF LOSARTAN THERAPY IN PATIENTS UNDERGOING DIABETIC END-STAGE RENAL DISEASE IN EU AND USA
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)72114-3&doi=10.1016/S1098-3015(11)72114-3
First page :
A294
Section Title :
RESEARCH POSTER ABSTRACTS
Open access? :
No
Section Order :
273